BIOLASE, INC. Net Change in Cash
BIOLASE, INC. reported Net Change in Cash of -$3.12 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-11-07
- BIOLASE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$173.00K, a 107.36% decline year-over-year.
- BIOLASE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $2.35M.
- BIOLASE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$8.37M, a 136.11% decline year-over-year.
- BIOLASE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $23.17M.
- BIOLASE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $2.38M.
- BIOLASE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$25.99M, a 311.35% decline from fiscal 2021.
- BIOLASE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $12.30M, a 4.45% increase from fiscal 2020.
- BIOLASE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $11.78M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$3.12M 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | -$1.29M 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | -$173.00K 10-Q · filed 2024-05-13 | |||
| 2023-12-31 | $2.38M 10-K · filed 2024-03-21 | |||
| 2023-09-30 | $3.63M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $2.75M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $2.35M 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | -$25.99M 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$20.21M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$10.63M 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$8.37M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $12.30M 10-K · filed 2024-03-21 | |||
| 2021-09-30 | $15.71M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $19.41M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $23.17M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $11.78M 10-K · filed 2023-03-28 | |||
| 2020-09-30 | $13.06M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | -$352.00K 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | -$4.28M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$2.25M 10-K · filed 2022-03-17 | |||
| 2019-09-30 | -$5.95M 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | -$4.32M 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | -$5.09M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | -$3.54M 10-K · filed 2021-03-31 | |||
| 2018-09-30 | -$9.46M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | -$8.75M 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | -$3.17M 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $2.72M 10-K · filed 2020-03-30 | |||
| 2017-09-30 | -$4.47M 10-Q · filed 2018-11-14 | |||
| 2017-06-30 | -$1.01M 10-Q · filed 2018-08-13 | |||
| 2017-03-31 | -$5.35M 10-Q · filed 2018-05-04 | |||
| 2016-12-31 | -$2.72M 10-K · filed 2019-03-08 |